|
1
|
Piyathilake CJ, Macaluso M, Johanning GL,
Whiteside M, Heimburger DC and Giuliano A:
Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases
the risk of cervical intraepithelial neoplasia. Anticancer Res.
20:1751–1757. 2000.PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Kohaar I, Kumar J, Thakur N, et al:
Homocysteine levels are associated with cervical cancer independent
of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms
in Indian population. Biomarkers. 15:61–68. 2010. View Article : Google Scholar
|
|
4
|
Kohaar I, Thakur N, Salhan S, et al:
TNFα-308G/A polymorphism as a risk factor for HPV-associated
cervical cancer in Indian population. Cell Oncol. 29:249–256.
2007.
|
|
5
|
García-Closas R, Castellsagué X, Bosch X
and González CA: The role of diet and nutrition in cervical
carcinogenesis: a review of recent evidence. Int J Cancer.
117:629–637. 2005.PubMed/NCBI
|
|
6
|
Tong SY, Kim MK, Lee JK, et al: Common
polymorphisms in methylenetetrahydrofolate reductase gene are
associated with risks of cervical intraepithelial neoplasia and
cervical cancer in women with low serum folate and vitamin B12.
Cancer Causes Control. 22:63–72. 2011. View Article : Google Scholar
|
|
7
|
Kjellberg L, Hallmans G, Ahren AM, et al:
Smoking, diet, pregnancy and oral contraceptive use as risk factors
for cervical intra-epithelial neoplasia in relation to human
papillomavirus infection. Br J Cancer. 82:1332–1338.
2000.PubMed/NCBI
|
|
8
|
Josefsson AM, Magnusson PK, Ylitalo N, et
al: Viral load of human papilloma virus 16 as a determinant for
development of cervical carcinoma in situ: a nested case-control
study. Lancet. 355:2189–2193. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gerhard DS, Nguyen LT, Zhang ZY, Borecki
IB, Coleman BI and Rader JS: A relationship between
methylenetetrahydrofolate reductase variants and the development of
invasive cervical cancer. Gynecol Oncol. 90:560–565. 2003.
View Article : Google Scholar
|
|
10
|
Yamada K, Chen Z, Rozen R and Matthews RG:
Effects of common polymorphisms on the properties of recombinant
human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA.
98:14853–14858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tong SY, Lee JM, Song ES, et al: The
effects of polymorphisms in methylenetetrahydrofolate reductase
(MTHFR), methionine synthase (MTR), and methionine synthase
reductase (MTRR) on the risk of cervical intraepithelial neoplasia
and cervical cancer in Korean women. Cancer Causes Control.
21:23–30. 2010. View Article : Google Scholar
|
|
12
|
Prasad VV and Wilkhoo H: Association of
the functional polymorphism C677T in the methylenetetrahydrofolate
reductase gene with colorectal, thyroid, breast, ovarian, and
cervical cancers. Onkologie. 34:422–426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goodman MT, McDuffie K, Hernandez B, et
al: Association of methylenetetrahydrofolate reductase polymorphism
C677T and dietary folate with the risk of cervical dysplasia.
Cancer Epidemiol Biomarkers Prev. 10:1275–1280. 2001.PubMed/NCBI
|
|
14
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
15
|
Kang S, Kim JW, Kang GH, Park NH, Song YS,
Kang SB and Lee HP: Polymorphism in folate- and
methionine-metabolizing enzyme and aberrant CpG island
hypermethylation in uterine cervical cancer. Gynecol Oncol.
96:173–180. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Powers HJ: Interaction among folate,
riboflavin, genotype, and cancer, with reference to colorectal and
cervical cancer. J Nutr. 135(Suppl 12): S2960–S2966.
2005.PubMed/NCBI
|
|
17
|
Zoodsma M, Nolte IM, Schipper M, et al:
Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for
(pre)neoplastic cervical disease. Hum Genet. 116:247–254. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hazra A, Wu K, Kraft P, Fuchs CS,
Giovannucci EL and Hunter DJ: Twenty-four non-synonymous
polymorphisms in the one-carbon metabolic pathway and risk of
colorectal adenoma in the Nurses’ Health Study. Carcinogenesis.
28:1510–1519. 2007.PubMed/NCBI
|
|
19
|
Stroup DF, Berlin JA, Morton SC, et al:
Meta-analysis of observational studies in epidemiology: a proposal
for reporting. Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar
|
|
20
|
Qi X, Ma X, Yang X, et al:
Methylenetetrahydrofolate reductase polymorphisms and breast cancer
risk: a meta-analysis from 41 studies with 16,480 cases and 22,388
controls. Breast Cancer Res Treat. 123:499–506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sull JW, Jee SH, Yi S, et al: The effect
of methylenetetrahydrofolate reductase polymorphism C677T on
cervical cancer in Korean women. Gynecol Oncol. 95:557–563. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shekari M, Sobti RC, Kordi Tamandani DM,
et al: Impact of methylenetetrahydrofolate reductase (MTHFR) codon
(677) and methionine synthase (MS) codon (2756) on risk of cervical
carcinogenesis in North Indian population. Arch Gynecol Obstet.
278:517–524. 2008. View Article : Google Scholar
|
|
23
|
Mostowska A, Myka M, Lianeri M, Roszak A
and Jagodziński PP: Folate and choline metabolism gene variants and
development of uterine cervical carcinoma. Clin Biochem.
44:596–600. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lambropoulos AF, Agorastos T, Foka ZJ,
Chrisafi S, Constantinidis TC, Bontis J and Kotsis A:
Methylenetetrahydrofolate reductase polymorphism C677T is not
associated to the risk of cervical dysplasia. Cancer Lett.
191:187–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Delgado-Enciso I, Martínez-Garza SG,
Rojas-Martínez A, et al: The effect of MTHFR polymorphisms,
pregnancy and first intercourse on cervical cancer in a population
from the Northeastern Mexico. Rev Invest Clin. 58:462–469. 2006.(In
Spanish).
|
|
26
|
Piyathilake CJ, Azrad M, Macaluso M,
Johanning GL, Cornwell PE, Partridge EE and Heimburger DC:
Protective association of MTHFR polymorphism on cervical
intraepithelial neoplasia is modified by riboflavin status.
Nutrition. 23:229–235. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang JT, Ma XC, Cheng YY, Ding L and Zhou
Q: A case-control study on the association between folate and
cervical cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 27:424–427.
2006.(In Chinese).
|
|
28
|
Agodi A, Barchitta M, Cipresso R, et al:
Distribution of p53, GST, and MTHFR polymorphisms and risk of
cervical intraepithelial lesions in sicily. Int J Gynecol Cancer.
20:141–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Muñoz N, Bosch FX, de Sanjosé S, et al;
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group. Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003.
|
|
30
|
Hemminki K, Dong C and Vaittinen P:
Familial risks in cervical cancer: is there a hereditary component?
Int J Cancer. 82:775–781. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Blount BC, Mack MM, Wehr CM, et al: Folate
deficiency causes uracil misincorporation into human DNA and
chromosome breakage: implications for cancer and neuronal damage.
Proc Natl Acad Sci USA. 94:3290–3295. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Esteller M and Herman JG: Cancer as an
epigenetic disease: DNA methylation and chromatin alterations in
human tumours. J Pathol. 196:1–7. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fowler BM, Giuliano AR, Piyathilake C,
Nour M and Hatch K: Hypomethylation in cervical tissue: is there a
correlation with folate status? Cancer Epidemiol Biomarkers Prev.
7:901–906. 1998.PubMed/NCBI
|
|
34
|
Weisberg I, Tran P, Christensen B, Sibani
S and Rozen R: A second genetic polymorphism in
methylenetetrahydrofolate reductase (MTHFR) associated with
decreased enzyme activity. Mol Genet Metab. 64:169–172. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rao GG, Kurien A, Gossett D, Griffith WF,
Coleman RL and Muller CY: A case-control study of
methylenetetrahydrofolate reductase polymorphisms in cervical
carcinogenesis. Gynecol Oncol. 101:250–254. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hubner RA and Houlston RS: MTHFR C677T and
colorectal cancer risk: a meta-analysis of 25 populations. Int J
Cancer. 120:1027–1035. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen J, Giovannucci E, Kelsey K, et al: A
methylenetetrahydrofolate reductase polymorphism and the risk of
colorectal cancer. Cancer Res. 56:4862–4864. 1996.PubMed/NCBI
|
|
38
|
Hankey GJ and Eikelboom JW: Homocysteine
and stroke. Lancet. 365:194–196. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Magnusson PK, Sparén P and Gyllensten UB:
Genetic link to cervical tumours. Nature. 400:29–30. 1999.
View Article : Google Scholar : PubMed/NCBI
|
